These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Structure and function of protein C. Stenflo J. Semin Thromb Hemost; 1984 Apr; 10(2):109-21. PubMed ID: 6429858 [No Abstract] [Full Text] [Related]
25. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A, Ruusuvaara L. Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043 [Abstract] [Full Text] [Related]
27. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Büller HR, Rosing J. Thromb Haemost; 2000 Jul 22; 84(1):15-21. PubMed ID: 10928463 [Abstract] [Full Text] [Related]
28. The natural anticoagulants. Salem HH. Clin Haematol; 1986 May 22; 15(2):371-91. PubMed ID: 3015466 [No Abstract] [Full Text] [Related]
31. [Anticoagulant protein C system: structure and function]. Martín García E. Rev Clin Esp; 1988 Sep 22; 183(4):197-203. PubMed ID: 2854287 [No Abstract] [Full Text] [Related]
32. [Protein C, protein S and thrombomodulin: one of the natural antithrombotic mechanisms]. Lobato-Mendizábal E, Ruiz-Argüelles GJ. Rev Invest Clin; 1990 Sep 22; 42(1):54-62. PubMed ID: 2173090 [Abstract] [Full Text] [Related]
33. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation. Mosnier LO, Elisen MG, Bouma BN, Meijers JC. Thromb Haemost; 2001 Oct 22; 86(4):1057-64. PubMed ID: 11686324 [Abstract] [Full Text] [Related]
35. Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects. Okajima K, Koga S, Kaji M, Inoue M, Nakagaki T, Funatsu A, Okabe H, Takatsuki K, Aoki N. Thromb Haemost; 1990 Feb 19; 63(1):48-53. PubMed ID: 2140205 [Abstract] [Full Text] [Related]
36. [A new anticoagulative system--protein C system]. Wu MP. Sheng Li Ke Xue Jin Zhan; 1991 Jan 19; 22(1):65-8. PubMed ID: 1648258 [No Abstract] [Full Text] [Related]
37. Isolation and characterization of single-chain protein S. Meijer-Huizinga F, Mertens K, van Mourik JA. Thromb Haemost; 1994 Sep 19; 72(3):408-14. PubMed ID: 7531875 [Abstract] [Full Text] [Related]
38. [Vitronectin in normal human skin and in skin lesions]. Hintner H, Breathnach SM, Dahlbäck K, Dahlbäck B, Fritsch P. Hautarzt; 1991 Jan 19; 42(1):16-22. PubMed ID: 1707041 [Abstract] [Full Text] [Related]
39. Peritoneal lavage with activated protein C alters compartmentalized coagulation and fibrinolysis and improves survival in polymicrobial peritonitis. van Veen SQ, Levi M, van Vliet AK, Florquin S, van Gulik TM, Boermeester MA. Crit Care Med; 2006 Nov 19; 34(11):2799-805. PubMed ID: 17006359 [Abstract] [Full Text] [Related]
40. Hypercoagulable states: new knowledge about old problems. Moake JL. Hosp Pract (Off Ed); 1991 Mar 30; 26(3A):31-42. PubMed ID: 1826007 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]